SG
ANVS icon

StoneX Group’s Annovis Bio ANVS Stock Holding History

StoneX Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.5K Buy
+14,465
New +$28.1K ﹤0.01% 1278

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

StoneX Group's ANVS Position: Q2 2026 in Review

StoneX Group opened a new position in Annovis Bio (ANVS) in Q2 2026: 14,465 shares worth $28.5K. The stake represents ﹤0.01% of the portfolio and ranks #1278 among its holdings.

61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • StoneX Group held 14,465 shares of Annovis Bio worth $28.5K as of Q2 2026.
  • Annovis Bio was a new StoneX Group position in Q2 2026.
  • Annovis Bio made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1278 holding.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.